Company
IndiaCdymax (India) Pharma Private Limited, Bangalore, India – FDA Inspections
Inspection records and compliance data for Cdymax (India) Pharma Private Limited in Bangalore. 4 FDA inspections on record (1 OAI), 2 Form 483s, 1 warning letter, last inspected April 25, 2025.
Company Profile
This profile covers Cdymax (India) Pharma Private Limited based in Bangalore, India.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 1
- VAI
- 2
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 1
First inspected August 14, 2015. Last inspected April 25, 2025.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 25, 2025 | OAI | Human Drugs · Drug Quality Assurance | 1271325 |
| January 31, 2020 | VAI | Human Drugs · Drug Quality Assurance | 1118683 |
| May 17, 2019 | Not classified | Human Drugs | 1093684 |
| August 14, 2015 | VAI | Human Drugs · Drug Quality Assurance | 940635 |
FDA documents
Form 483s (2)
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Cdymax (India) Pharma Private Limited
FEI Number
3009882550
Address
77d & 116/117, Kiadb Industrial Area, Jigani, Bangalore, India
Country
India
ID: 51bc8d84-9900-43c0-8e1c-9d2bd08b0ac4